CN100478027C - 导管组合物及其制备药物的用途 - Google Patents

导管组合物及其制备药物的用途 Download PDF

Info

Publication number
CN100478027C
CN100478027C CNB028275578A CN02827557A CN100478027C CN 100478027 C CN100478027 C CN 100478027C CN B028275578 A CNB028275578 A CN B028275578A CN 02827557 A CN02827557 A CN 02827557A CN 100478027 C CN100478027 C CN 100478027C
Authority
CN
China
Prior art keywords
conduit
sample
plasminogen activator
compositions
test
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB028275578A
Other languages
English (en)
Chinese (zh)
Other versions
CN1617738A (zh
Inventor
查尔斯·P·塞巴
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of CN1617738A publication Critical patent/CN1617738A/zh
Application granted granted Critical
Publication of CN100478027C publication Critical patent/CN100478027C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49—Urokinase; Tissue plasminogen activator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Detergent Compositions (AREA)
CNB028275578A 2001-11-26 2002-11-25 导管组合物及其制备药物的用途 Expired - Fee Related CN100478027C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33336901P 2001-11-26 2001-11-26
US60/333,369 2001-11-26

Publications (2)

Publication Number Publication Date
CN1617738A CN1617738A (zh) 2005-05-18
CN100478027C true CN100478027C (zh) 2009-04-15

Family

ID=23302492

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB028275578A Expired - Fee Related CN100478027C (zh) 2001-11-26 2002-11-25 导管组合物及其制备药物的用途

Country Status (28)

Country Link
US (3) US20030206906A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP1455858A4 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP4458240B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (2) KR20100102745A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN100478027C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AR (1) AR037437A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (2) AU2002365408B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR0215098A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2467645C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CO (1) CO5580795A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EA (1) EA007594B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EC (2) ECSP045123A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HR (1) HRP20040502A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
HU (1) HUP0600436A3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (2) IL162083A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IS (1) IS7275A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ME (1) ME00015B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MXPA04004948A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MY (1) MY140404A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO331700B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ533029A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
PL (1) PL371760A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
RS (1) RS46204A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TWI262794B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
UA (1) UA81235C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
UY (1) UY27550A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO2003045466A2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA200404024B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04004948A (es) * 2001-11-26 2004-08-11 Genentech Inc Composicion de cateter y sus usos.
US7128923B2 (en) * 2003-03-31 2006-10-31 Procyte Corporation Preserved and stable compositions containing peptide copper complexes and method related thereto
CA2662083C (en) * 2006-08-28 2016-09-20 Omnio Healer Ab Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health
CA2662101C (en) * 2006-08-28 2015-07-07 Omnio Healer Ab Candidates against infection
JP5871449B2 (ja) * 2006-11-07 2016-03-01 ジェネンテック， インコーポレイテッド 組織プラスミノゲン活性化因子バリアントの使用
RU2323001C1 (ru) * 2007-05-30 2008-04-27 Общество с ограниченной ответственностью "Научно-производственное предприятие "Техноген" Фармацевтическая композиция, обладающая фибринолитическим действием
WO2008150375A1 (en) 2007-06-01 2008-12-11 Arrow International, Inc. Combined fibrinolytic and antimicrobial catheter and uses thereof
CN103181893A (zh) * 2007-09-07 2013-07-03 联合治疗公司 针对革兰氏阴性细菌具有选择性杀菌活性的缓冲液及其使用方法
US8545459B2 (en) * 2009-02-25 2013-10-01 Teleflex Medical Incorporated Stabilized enzyme compositions
US9333280B2 (en) 2009-02-25 2016-05-10 Teleflex Medical Incorporated Stabilized enzyme compositions
EP2464406B1 (en) * 2009-08-10 2016-10-26 Proviflo, LLC Catheter lock solutions utilizing tocopherol and mid-chain fatty acids
CN103083726A (zh) * 2013-03-04 2013-05-08 昆明市第一人民医院 一种肝脏组织脱细胞液
WO2016201269A2 (en) 2015-06-11 2016-12-15 Proviflo, Llc Graft-port hemodialysis systems, devices and methods

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI831484A7 (fi) * 1982-05-05 1983-11-06 Genentech Inc Ihmiskudoksen plasminogeenien aktivaattori.
US5000185A (en) * 1986-02-28 1991-03-19 Cardiovascular Imaging Systems, Inc. Method for intravascular two-dimensional ultrasonography and recanalization
US5019096A (en) * 1988-02-11 1991-05-28 Trustees Of Columbia University In The City Of New York Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same
US5270198A (en) * 1988-05-20 1993-12-14 Genentech, Inc. DNA molecules encoding variants of tissue plasminogen activators, vectors, and host cells
GB8820945D0 (en) * 1988-09-07 1988-10-05 Smith & Nephew Medical articles
FR2661790B1 (fr) * 1990-05-03 1995-08-25 France Etat Dispositif d'amplification tres large bande continu-hyperfrequences, notamment realisable en circuit integre.
AU7998091A (en) * 1990-05-17 1991-12-10 Harbor Medical Devices, Inc. Medical device polymer
US5399158A (en) * 1990-05-31 1995-03-21 The United States Of America As Represented By The Secretary Of The Army Method of lysing thrombi
US5363754A (en) * 1991-09-03 1994-11-15 Grainco Queensland Co-Operative Association Limited Apparatus for preparing animal feedstuff from cotton seed
JPH05291891A (ja) * 1992-02-14 1993-11-05 Ricoh Co Ltd 一次乱数パルス列発生回路装置
ATE246000T1 (de) * 1992-06-03 2003-08-15 Genentech Inc Varianten des gewebeplasminogenaktivators mit verbesserter therapeutischer wirkung
US5688516A (en) * 1992-11-12 1997-11-18 Board Of Regents, The University Of Texas System Non-glycopeptide antimicrobial agents in combination with an anticoagulant, an antithrombotic or a chelating agent, and their uses in, for example, the preparation of medical devices
US5362754A (en) * 1992-11-12 1994-11-08 Univ. Of Tx Md Anderson Cancer Center M-EDTA pharmaceutical preparations and uses thereof
NZ276633A (en) 1993-11-24 1998-04-27 Du Pont Merck Pharma Isoxazole and isoxazoline derivatives and pharmaceutical compositions thereof
US5849736A (en) * 1993-11-24 1998-12-15 The Dupont Merck Pharmaceutical Company Isoxazoline and isoxazole fibrinogen receptor antagonists
US5885967A (en) * 1994-03-04 1999-03-23 Eli Lilly And Company Antithrombotic agents
US5509896A (en) * 1994-09-09 1996-04-23 Coraje, Inc. Enhancement of thrombolysis with external ultrasound
US5772640A (en) * 1996-01-05 1998-06-30 The Trustees Of Columbia University Of The City Of New York Triclosan-containing medical devices
CA2178541C (en) * 1995-06-07 2009-11-24 Neal E. Fearnot Implantable medical device
US5932299A (en) * 1996-04-23 1999-08-03 Katoot; Mohammad W. Method for modifying the surface of an object
US5840733A (en) * 1996-07-01 1998-11-24 Redcell, Canada, Inc. Methods and compositions for producing novel conjugates of thrombin inhibitors and endogenous carriers resulting in anti-thrombins with extended lifetimes
US5837688A (en) * 1996-11-27 1998-11-17 Gelfand; Mathew I. Use of thrombolytic reagents for prevention of vascular disease
GB9626795D0 (en) * 1996-12-23 1997-02-12 Geistlich Soehne Ag Combating infection in delivery systems
AU5526098A (en) 1996-12-23 1998-07-17 Biochem Pharma Inc. Bicyclic thrombin inhibitors
US5981826A (en) * 1997-05-05 1999-11-09 Georgia Tech Research Corporation Poly(vinyl alcohol) cryogel
JPH10328293A (ja) 1997-06-04 1998-12-15 Unitika Ltd 医療用具及びその製造方法
US6206914B1 (en) * 1998-04-30 2001-03-27 Medtronic, Inc. Implantable system with drug-eluting cells for on-demand local drug delivery
US6166007A (en) * 1998-07-02 2000-12-26 Sodemann; Klaus Antimicrobial locks comprising taurinamide derivatives and carboxylic acids and/or salts thereof
US6174537B1 (en) * 1998-09-25 2001-01-16 Becton, Dickinson And Company Catheter flush solution and method for its use
AR022909A1 (es) * 1999-03-11 2002-09-04 Du Pont Pharm Co Sinergia entre heparina de bajo peso molecular e inhibidores de la agregacion plaquetaria, que provee una terapia combinada para la prevencion ytratamiento de diversas afecciones tromboembolicas
IL144798A0 (en) 1999-03-11 2002-06-30 Du Pont Pharm Co Treatment of thrombosis by combined use of a factor xa inhibitor and aspirin, tissue plasminogen activator (tpa), a gpiib/iiia antagonist, low molecular weight heparin or heparin
CA2302720C (en) 1999-03-29 2009-07-14 Ed Geistlich Sohne Ag Fur Chemische Industrie Anticoagulant/sterilizing compositions and methods
US6187768B1 (en) * 1999-06-01 2001-02-13 Becton, Dickinson And Company Kit for flushing medical devices and method of preparation
EP1060747A3 (en) * 1999-06-16 2001-12-05 New York Blood Center, Inc. Fibrin(ogen) degradation and clot lysis by fibrinolytic metalloproteinase
US6592564B2 (en) * 1999-07-23 2003-07-15 Vasca, Inc. Methods and kits for locking and disinfecting implanted catheters
US6350251B1 (en) * 2000-01-18 2002-02-26 Biolink Corporation Biocidal locks
US20010031981A1 (en) * 2000-03-31 2001-10-18 Evans Michael A. Method and device for locating guidewire and treating chronic total occlusions
JP2005517460A (ja) 2000-05-10 2005-06-16 アッシュ・アクセス・テクノロジー・インコーポレーテッド 光酸化剤を含むカテーテルロック溶液
US6772640B1 (en) * 2000-10-10 2004-08-10 Mks Instruments, Inc. Multi-temperature heater for use with pressure transducers
US20050215978A1 (en) * 2001-05-25 2005-09-29 Ash Stephen R Method of enhancing catheter patency using a citrate salt catheter lock solution
MXPA04004948A (es) * 2001-11-26 2004-08-11 Genentech Inc Composicion de cateter y sus usos.
US20070014779A1 (en) * 2002-11-14 2007-01-18 Genentech, Inc. Plasminogen activator variant formulations
ATE354380T1 (de) 2003-02-03 2007-03-15 Polaschegg Hans-Dietrich Dr Te Zusammensetzung zur prävention von infektionen durch subkutane prothesen
US7696182B2 (en) 2004-11-02 2010-04-13 Nd Partners, Llc Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin
US7749529B2 (en) 2005-02-08 2010-07-06 Ash Access Technology, Inc. Catheter lock solution comprising citrate and a paraben
JP5871449B2 (ja) 2006-11-07 2016-03-01 ジェネンテック， インコーポレイテッド 組織プラスミノゲン活性化因子バリアントの使用

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
catheter-directed thrombolysis for the treatment of acute deepvenous thrombosis. Meghal R. Antani.supplement to applied radiology,Vol.30 No.7. 2001 *
comparison of streptonkinase. urokinase, and recombinanttissue plasminogen activator in an in vitro model of venousthrombolysis. Ouriel k, et al.journal of vascular surgery,Vol.22 No.5. 1995 *
乙醇在医院的几种新用途. 张声亮.福建医药杂志，第22卷第6期. 2000 *

Also Published As

Publication number Publication date
HUP0600436A2 (en) 2006-09-28
JP2005510302A (ja) 2005-04-21
CN1617738A (zh) 2005-05-18
NZ533029A (en) 2006-05-26
ME00015B (me) 2010-06-10
US7829082B2 (en) 2010-11-09
MEP8008A (xx) 2010-02-10
TWI262794B (en) 2006-10-01
EA007594B1 (ru) 2006-12-29
WO2003045466A2 (en) 2003-06-05
WO2003045466A3 (en) 2003-10-09
TW200303743A (en) 2003-09-16
EP1455858A4 (en) 2006-02-15
CA2467645C (en) 2017-01-17
ECSDI045123S (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2004-07-23
RS46204A (en) 2006-10-27
US20060257390A1 (en) 2006-11-16
BR0215098A (pt) 2004-12-14
AU2002365408B2 (en) 2008-04-24
KR20100102745A (ko) 2010-09-24
AU2008203131A1 (en) 2008-08-07
IS7275A (is) 2004-05-21
NO331700B1 (no) 2012-02-27
CA2467645A1 (en) 2003-06-05
ZA200404024B (en) 2005-07-27
NO20042693L (no) 2004-08-25
AR037437A1 (es) 2004-11-10
US20060246050A1 (en) 2006-11-02
EP1455858A2 (en) 2004-09-15
UA81235C2 (en) 2007-12-25
HRP20040502A2 (en) 2004-12-31
EA200400712A1 (ru) 2005-06-30
IL162083A (en) 2012-12-31
IL162083A0 (en) 2005-11-20
MY140404A (en) 2009-12-31
CO5580795A2 (es) 2005-11-30
JP4458240B2 (ja) 2010-04-28
AU2002365408A1 (en) 2003-06-10
US20030206906A1 (en) 2003-11-06
PL371760A1 (en) 2005-06-27
MXPA04004948A (es) 2004-08-11
HUP0600436A3 (en) 2010-12-28
ECSP045123A (es) 2004-07-23
UY27550A1 (es) 2003-06-30
KR20040054803A (ko) 2004-06-25

Similar Documents

Publication Publication Date Title
US7829082B2 (en) Catheter composition and uses thereof
Pearson et al. Guideline for prevention of intravascular-device–related infections
EP2440261B1 (en) A catheter locking solution having antimicrobial and anticoagulation properties
RU2734929C2 (ru) Раствор замка катетера и терапия с применением замка катетера
Berns et al. Preventing bacterial infections and antimicrobial resistance in dialysis patients
CN113425719A (zh) H2dpa及其衍生物作为金属β-内酰胺酶抑制剂在抗菌中应用
TW200826981A (en) Tissue plasminogen activator variant uses
US7662607B2 (en) Chalaropsis lysozyme protein and its method of use in anti-bacterial applications
KR101860976B1 (ko) 경피 정맥 접근 로킹 용액
Lal et al. British Intestinal Failure Alliance (BIFA) Recommendation Management of Catheter Related Blood Stream Infections (CRBSIs)
Lentz et al. In vitro stability and compatibility of tenecteplase in central venous access devices
RU2783927C2 (ru) Раствор замка катетера и терапия с применением замка катетера
Weck et al. Alteplase as a catheter locking solution: in vitro evaluation of biochemical stability and antimicrobial properties
Winnett et al. Trisodium citrate (TSC) 46.7% selectively and safely reduces staphylococcal catheter-related bacteraemia (CRB)
HK1259863A1 (en) Catheter locking solution and catheter locking therapy
HK1094320B (en) Antiseptic compositions, methods and systems
HK1094320A1 (en) Antiseptic compositions, methods and systems

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20090415

Termination date: 20141125

EXPY Termination of patent right or utility model